Insider Transactions in Q3 2022 at Nuvectis Pharma, Inc. (NVCT)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 30
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.02%
|
$3,500
$7.46 P/Share
|
Sep 28
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.02%
|
$3,500
$7.23 P/Share
|
Sep 26
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.02%
|
$3,500
$7.69 P/Share
|
Sep 23
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.03%
|
$7,000
$7.93 P/Share
|
Sep 23
2022
|
Shay Shemesh Chief Dev. & Ops. Officer |
BUY
Open market or private purchase
|
Direct |
220
+0.02%
|
$1,540
$7.87 P/Share
|
Sep 02
2022
|
Shay Shemesh Chief Dev. & Ops. Officer |
BUY
Open market or private purchase
|
Direct |
404
+0.03%
|
$3,232
$8.31 P/Share
|
Sep 02
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
1,200
+0.04%
|
$9,600
$8.37 P/Share
|
Sep 01
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.02%
|
$4,000
$8.11 P/Share
|
Sep 01
2022
|
Shay Shemesh Chief Dev. & Ops. Officer |
BUY
Open market or private purchase
|
Direct |
1,530
+0.12%
|
$12,240
$8.07 P/Share
|
Aug 31
2022
|
Shay Shemesh Chief Dev. & Ops. Officer |
BUY
Open market or private purchase
|
Direct |
1,476
+0.12%
|
$11,808
$8.07 P/Share
|
Aug 29
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.03%
|
$9,000
$9.07 P/Share
|
Aug 23
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.02%
|
$4,500
$9.0 P/Share
|
Aug 19
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.17%
|
$40,000
$8.99 P/Share
|
Aug 18
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
14,426
+0.48%
|
$115,408
$8.58 P/Share
|
Aug 11
2022
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
19,669
+0.65%
|
$157,352
$8.4 P/Share
|